Evidence map›Paper›PMID 34948187›Full record

ArticleInternational journal of molecular sciences2021

A Fibrin Coating Method of Polypropylene Meshes Enables the Adhesion of Menstrual Blood-Derived Mesenchymal Stromal Cells: A New Delivery Strategy for Stem Cell-Based Therapies.

Federica Marinaro, Joana M Silva, Alexandre A Barros, Ivo M Aroso, Juan C Gómez-Blanco, Isaac Jardin, Jose J Lopez, María Pulido, María Ángeles de Pedro, Rui L Reis and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Federica MarinaroStem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, 10071 Cáceres, Spain.ORCID 0000-0001-5965-7718
Joana M Silva3B's Research Group, I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Avepark, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal.
Alexandre A Barros3B's Research Group, I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Avepark, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal.
Ivo M Aroso3B's Research Group, I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Avepark, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal.ORCID 0000-0002-0543-548X
Juan C Gómez-BlancoStem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, 10071 Cáceres, Spain.ORCID 0000-0002-4354-5313
Isaac JardinCell Physiology Research Group, Department of Physiology, University of Extremadura, 10003 Cáceres, Spain.ORCID 0000-0003-4575-8264
Jose J LopezCell Physiology Research Group, Department of Physiology, University of Extremadura, 10003 Cáceres, Spain.ORCID 0000-0002-5234-1478
María PulidoStem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, 10071 Cáceres, Spain.
María Ángeles de PedroStem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, 10071 Cáceres, Spain.
Rui L Reis3B's Research Group, I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Avepark, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal.
Francisco Miguel Sánchez-MargalloStem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, 10071 Cáceres, Spain.ORCID 0000-0003-2138-988X
Javier G CasadoInstitute of Molecular Pathology Biomarkers, University of Extremadura, 10003 Cáceres, Spain.ORCID 0000-0001-6797-7287
Esther LópezStem Cell Therapy Unit, Jesús Usón Minimally Invasive Surgery Centre, 10071 Cáceres, Spain.ORCID 0000-0002-5051-5913
Centro de Cirugía de Mínima Invasión Jesús Usón · ESUniversity of Minho · PTCentro de Investigación en Red en Enfermedades Cardiovasculares · ESUniversidad de Extremadura · ES

Funding

Banco Santander (Spain) Convenio de colaboración empresarial en actividades de interés generalCentro de Investigación en Red en Enfermedades Cardiovasculares CB16/11/00494Fundação para a Ciência e Tecnologia CEECIND/01026/2018Government of Extremadura GR18199Government of Extremadura IB20184Government of Extremadura TA18011Government of Extremadura TA18054Instituto de Salud Carlos III CD19/00048Instituto de Salud Carlos III CP17/00021Instituto de Salud Carlos III FI19/00041Instituto de Salud Carlos III MS17/00021Instituto de Salud Carlos III PI18/0911
6 · The paper itself

Abstract

Polypropylene (PP) mesh is well-known as a gold standard of all prosthetic materials of choice for the reinforcement of soft tissues in case of hernia, organ prolapse, and urinary incontinence. The adverse effects that follow surgical mesh implantation remain an unmet medical challenge. Herein, it is outlined a new approach to allow viability and adhesion of human menstrual blood-derived mesenchymal stromal cells (MenSCs) on PP surgical meshes. A multilayered fibrin coating, based on fibrinogen and thrombin from a commercial fibrin sealant, was optimized to guarantee a homogeneous and stratified film on PP mesh. MenSCs were seeded on the optimized fibrin-coated meshes and their adhesion, viability, phenotype, gene expression, and immunomodulatory capacity were fully evaluated. This coating guaranteed MenSC viability, adhesion and did not trigger any change in their stemness and inflammatory profile. Additionally, MenSCs seeded on fibrin-coated meshes significantly decreased CD4+ and CD8+ T cell proliferation, compared to in vitro stimulated lymphocytes (

Indexed as

AdultCell AdhesionCell SeparationCoated Materials, BiocompatibleFemaleFibrinFibrin Tissue AdhesiveHumansMaterials TestingMenstruationMesenchymal Stem CellsPolypropylenesProstheses and ImplantsSurgical MeshTissue AdhesionsCoated Materials, BiocompatibleFibrinFibrin Tissue AdhesivePolypropylenescell therapycoatingfibrinfibrin sealantmenstrual blood-derived stromal cellssurgical mesh

Identifiers

PMID34948187
PMCPMC8706515
OpenAlexW4200365477

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.